Rafe B. Hanahan

Managing Director

(415) 962-2960
rhanahan@cainbrothers.com
Download vCard

Cain Brothers Experience

Rafe Hanahan co-leads Cain Brothers’ Medical Technologies Advisory practice. Mr. Hanahan joined Cain Brothers in 2015 and has 18 years’ experience advising both public and private companies in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Hanahan’s notable transactions include the sale of SW Holdings to MW Industries; the sale of ClearCorrect LLC to the Straumann Group; the sale of Collagen Matrix to MetalMark Capital; debt financing for Linden Capital’s acquisition of Avalign Technologies, debt financing for Viant’s acquisition of Integer’s Advanced Surgical & Orthopedics division, bond offerings for Abbott, Biomet, Boston Scientific, C.R. Bard, DJO Global, and Zimmer, and equity offerings for Integra LifeSciences, LDR Spine, and TransEnterix, among others.

Prior Experience

Prior to joining Cain Brothers, Mr. Hanahan covered medical technology and devices at RBC Capital Markets.  Prior to RBC, Mr. Hanahan was at Trivest Partners, a middle-market private equity firm, and at Bear Stearns in that firm’s Global Healthcare Group.

Education

Mr. Hanahan graduated from the Lundquist College of Business at the University of Oregon (Finance) and received an M.B.A from the Goizueta Business School at Emory University (Finance & Leadership).